Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Danone Said in Talks to Sell Its Medical Unit to Hospira

Danone's Consumer Brands
Exiting the business would help Danone, the world’s largest yogurt producer, focus on its food and consumer brands. Photographer: Simon Dawson/Bloomberg

July 28 (Bloomberg) -- Danone, the French consumer products maker, is in talks with Hospira Inc. as a potential buyer for a medical nutrition unit, a person familiar with the matter said.

The companies continue to negotiate a deal for the unit, said the person, who asked not to be identified because the discussions are private. Bloomberg News, citing people familiar with the situation, reported the unit was for sale in May and valued at more than 3 billion euros ($4 billion). Paris-based Danone had also talked to Vevey, Switzerland-based Nestle SA and Bad Homburg, Germany-based Fresenius SE, Bloomberg reported.

Exiting the business would help Danone, the world’s largest yogurt producer, focus on its food and consumer brands. Hospira, a Lake Forest, Illinois-based maker of injectable drugs, appears to be the most likely buyer, the person said. The Hospira talks were reported yesterday by the Financial Times on its website.

Daniel Rosenberg, spokesman for Hospira, didn’t respond to a call and e-mailed request for comment. Calls to Danone also weren’t immediately returned.

Sales at the Danone unit, whose products include Fortimel to counter malnutrition and Neocate, a hypoallergenic product for children, rose 5.2 percent in the first quarter on a like-for-like basis to 328 million euros. Revenue at the division was about 1.3 billion euros for all of last year, representing about 6.3 percent of the group total.

To contact the reporter on this story: David Welch in New York at dwelch12@bloomberg.net

To contact the editors responsible for this story: Jeffrey McCracken at jmccracken3@bloomberg.net Kevin Miller, Bruce Rule

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.